Literature DB >> 8894465

Gastric emptying in diabetes: an overview.

M Horowitz1, J M Wishart, K L Jones, G S Hebbard.   

Abstract

Gastric emptying is delayed in 30%-50% of patients with longstanding diabetes mellitus. The prevalence of disordered gastric emptying in patients with "early" Type 2 diabetes is controversial, but it has been suggested that gastric emptying is often accelerated. The pathogenesis of delayed gastric emptying in diabetes is poorly understood. It is, however, clear that acute changes in the blood glucose concentration have a major effect on gastric motor function and gastric emptying. There is an inverse relationship between the rate of gastric emptying and the blood glucose concentration, so that emptying is slower during hyperglycaemia and faster during hypoglycaemia. The motor dysfunctions responsible for delayed gastric emptying in patients with diabetes are heterogeneous. There is a high prevalence of upper gastrointestinal symptoms in diabetes. However, the correlation between symptoms and delay in gastric emptying is poor. Recent studies indicate that the blood glucose concentration modulates the perception of some sensations arising from the gastrointestinal tract. In both normal subjects and patients with diabetes the blood glucose response to oral carbohydrate and gastric emptying are related and there is evidence that modulation of the rate of gastric emptying, by dietary or pharmacological means, could be used to optimise glycaemic control. The use of prokinetic drugs, particularly cisapride, is currently the most effective approach to the treatment of symptomatic patients with gastroparesis. An improved understanding of the pathophysiology of both symptoms and delayed gastric emptying is fundamental to the development of more effective treatments.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8894465

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  35 in total

1.  What comes after macrolides and other motilin stimulants?

Authors:  J Tack; T Peeters
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

2.  Erythritol reduces small intestinal glucose absorption, increases muscle glucose uptake, improves glucose metabolic enzymes activities and increases expression of Glut-4 and IRS-1 in type 2 diabetic rats.

Authors:  Chika Ifeanyi Chukwuma; Ramgopal Mopuri; Savania Nagiah; Anil Amichund Chuturgoon; Md Shahidul Islam
Journal:  Eur J Nutr       Date:  2017-08-02       Impact factor: 5.614

Review 3.  Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.

Authors:  Miroslav Dostalek; Fatemeh Akhlaghi; Martina Puzanovova
Journal:  Clin Pharmacokinet       Date:  2012-08-01       Impact factor: 6.447

4.  The incidence, prevalence, and survival of gastroparesis in olmsted county, Minnesota, 1996-2006 (gastroenterology 2009;136:1225-1233).

Authors:  Hye-Kyung Jung
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

5.  Proximal gastric motility in critically ill patients with type 2 diabetes mellitus.

Authors:  Nam Q Nguyen; Robert J Fraser; Laura K Bryant; Marianne Chapman; Richard H Holloway
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

Review 6.  Treatment options for patients with severe gastroparesis.

Authors:  Hasse Abrahamsson
Journal:  Gut       Date:  2007-06       Impact factor: 23.059

Review 7.  Mechanisms underlying feed intolerance in the critically ill: implications for treatment.

Authors:  Adam Deane; Marianne J Chapman; Robert J Fraser; Laura K Bryant; Carly Burgstad; Nam Q Nguyen
Journal:  World J Gastroenterol       Date:  2007-08-07       Impact factor: 5.742

8.  Glucose increases synaptic transmission from vagal afferent central nerve terminals via modulation of 5-HT3 receptors.

Authors:  Shuxia Wan; Kirsteen N Browning
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-09-18       Impact factor: 4.052

Review 9.  Diabetes mellitus and the nervous system.

Authors:  P J Watkins; P K Thomas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-11       Impact factor: 10.154

10.  Increased function of inhibitory neuronal M2 muscarinic receptors in trachea and ileum of diabetic rats.

Authors:  Fiona R Coulson; David B Jacoby; Allison D Fryer
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.